来源平台：
相关网址：https://www.businesswire.com/news/home/20260517796615/en/New-Real-World-Case-Series-Examines-Re-Induction-with-ADSTILADRIN%C2%AE-nadofaragene-firadenovec-vncg-in-Clinical-Practice/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
